{"url_path":"/sec/cntx/8-k/2026-06-26/item-5-03","section_key":"item-5-03","section_title":"Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-26","source_url":"https://www.sec.gov/Archives/edgar/data/1842952/0001628280-26-045744-index.html","accession_number":"0001628280-26-045744","cik":"0001842952","ticker":"CNTX","issuer_name":"Context Therapeutics Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1842952/0001628280-26-045744-index.html","primary_entity_key":"0001842952","primary_entity_name":"Context Therapeutics Inc."},"word_count":125,"has_tables":true,"body_markdown":"Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.\n\nOn June 24, 2026, Context Therapeutics Inc. (the “Company”) held its Annual Meeting of Stockholders (the “Meeting”). At the Meeting, the Company’s stockholders approved, among other things, an amendment to the Company's Amended and Restated Certificate of Incorporation (the \"Certificate\") to increase the number of authorized shares of common stock from 200,000,000 to 300,000,000.\n\nA copy of the Certificate of Amendment to the Certificate to increase the number of authorized shares of common stock from 200,000,000 to 300,000,000, as filed with the Secretary of State of the State of Delaware on June 24, 2026, is attached as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference."}